US equities |
INTC $64.77 ▼-29.65% AMZN $238.69 ▼-2.09% MU $881.15 ▼-5.69% NVDA $205.48 ▼-3.83% SNDK $1,167.96 ▼-12.19% GOOGL $282.00 ▼-0.64% SPCX $138.26 ▼-3.91% TSLA $400.18 ▼-0.77%
FinancialContent

Articles published by AccuStem Sciences, Inc.

News headline image
AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Announce Strategic Clinical and Operational Partnership
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT
News headline image
AccuStem Announces Adjournment of Annual Meeting of Stockholders
From AccuStem Sciences, Inc.
Via GlobeNewswire
Tickers ACUT